GenoMirai Genome Analysis Platform Introduced in Tokyo

(Isstories Editorial):- San Jose, California Feb 19, 2026 (Issuewire.com) – GenoMirai Genome Analysis Platform Introduced in Tokyo

More on Isstories:

• Why Residential ESS Battery Systems Are Becoming Essential for Modern Energy Independence
• Optimizing Storage Space: Professional U-Panel FIBC Bags Solutions from China by Zsbulkbags
• Secure Chemical Logistics: Zsbulkbags, a Trusted High Quality Chemical Raw Material FIBC Supplier in China
• Custom Food Grade FIBC Manufacturer in China: Can Zsbulkbags Meet FDA-Compliant Packaging Needs?
• “Phoenix Star 2025 Hong Kong IPO Brand Report” Grandly Released, Focusing on the New IPO Ecosystem

GenoMirai, a genome information analysis platform established in 2025, has been launched in Tokyo to support research in genomics, bioinformatics, and digital health. The platform was founded by Jorge Remón García, a Spanish entrepreneur and technology executive specializing in artificial intelligence, blockchain, and healthcare systems.

GenoMirai provides researchers and medical professionals with tools to organize, search, and visualize complex genomic datasets. The platform’s structured data visualization and high-precision search capabilities allow users to query genes, disease terms, and clinically relevant markers efficiently.

The platform is intended to support workflows in precision medicine and biomedical research by providing accessible analytical tools for large-scale genomic information. GenoMirai is part of a broader ecosystem that integrates bioinformatics, AI-driven analytics, and secure data management.

Jorge Remón García, born in 1988, has a background in international studies and technology. He graduated with honors in African and East Asian Studies from the Autonomous University of Madrid and completed a Middle East Studies program at Columbia University. During an academic exchange at the United Arab Emirates University, he conducted research in robotics and artificial intelligence. He is a polyglot, speaking nine languages including Spanish, Chinese, and English at a native level, as well as advanced Arabic.

Professionally, Jorge Remón García has worked on projects combining health technology and fintech. His work includes developing AI-based predictive models for disease management and blockchain-based platforms for secure medical data sharing.

GenoMirai operates under Dicra, a Silicon Valley-based company co-founded by Jorge Remón García. Dicra focuses on AI and blockchain applications for healthcare. The Dicra.io team manages day-to-day operations and technical development, integrating GenoMirai with related projects in predictive medical analytics and secure health data systems.

As genomic research continues to expand globally, platforms like GenoMirai provide tools that help researchers and healthcare professionals analyze and interpret complex genetic information efficiently.

For more information about GenoMirai and its ongoing developments, visit https://genomirai.jp.

This article was originally published by IssueWire. Read the original article here.